These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20051940)

  • 1. Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels.
    Shin S; Shea LD
    Mol Ther; 2010 Apr; 18(4):700-6. PubMed ID: 20051940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo.
    Kidd ME; Shin S; Shea LD
    J Control Release; 2012 Jan; 157(1):80-5. PubMed ID: 21907251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable alginate hydrogel for enhanced spatiotemporal control of lentivector delivery in murine skeletal muscle.
    Stilhano RS; Madrigal JL; Wong K; Williams PA; Martin PK; Yamaguchi FS; Samoto VY; Han SW; Silva EA
    J Control Release; 2016 Sep; 237():42-9. PubMed ID: 27374631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-chitosan nanoparticle functionalization of porous poly(ethylene glycol) hydrogels for localized lentivirus delivery of angiogenic factors.
    Thomas AM; Gomez AJ; Palma JL; Yap WT; Shea LD
    Biomaterials; 2014 Oct; 35(30):8687-93. PubMed ID: 25023395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogels for lentiviral gene delivery.
    Seidlits SK; Gower RM; Shepard JA; Shea LD
    Expert Opin Drug Deliv; 2013 Apr; 10(4):499-509. PubMed ID: 23347508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained, localized transgene expression mediated from lentivirus-loaded biodegradable polyester elastomers.
    Jen MC; Baler K; Hood AR; Shin S; Shea LD; Ameer GA
    J Biomed Mater Res A; 2013 May; 101(5):1328-35. PubMed ID: 23065823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogel macroporosity and the prolongation of transgene expression and the enhancement of angiogenesis.
    Shepard JA; Virani FR; Goodman AG; Gossett TD; Shin S; Shea LD
    Biomaterials; 2012 Oct; 33(30):7412-21. PubMed ID: 22800542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-viral vector delivery from PEG-hyaluronic acid hydrogels.
    Wieland JA; Houchin-Ray TL; Shea LD
    J Control Release; 2007 Jul; 120(3):233-41. PubMed ID: 17582640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable and thermosensitive PLGA-g-PEG hydrogels containing hydroxyapatite: preparation, characterization and in vitro release behavior.
    Lin G; Cosimbescu L; Karin NJ; Tarasevich BJ
    Biomed Mater; 2012 Apr; 7(2):024107. PubMed ID: 22456931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis.
    S V; A S; Annapoorna M; R J; Subramania I; Shantikumar V N; R J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():129-138. PubMed ID: 29055865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized lentivirus delivery via peptide interactions.
    Skoumal M; Seidlits S; Shin S; Shea L
    Biotechnol Bioeng; 2016 Sep; 113(9):2033-40. PubMed ID: 26913962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable supramolecular hydrogel formed from α-cyclodextrin and PEGylated arginine-functionalized poly(l-lysine) dendron for sustained MMP-9 shRNA plasmid delivery.
    Lin Q; Yang Y; Hu Q; Guo Z; Liu T; Xu J; Wu J; Kirk TB; Ma D; Xue W
    Acta Biomater; 2017 Feb; 49():456-471. PubMed ID: 27915016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral Vectors Delivered with Biomaterials as Therapeutics for Spinal Cord Injury.
    Shortiss C; Howard L; McMahon SS
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin hydrogels for non-viral vector delivery in vitro.
    des Rieux A; Shikanov A; Shea LD
    J Control Release; 2009 Jun; 136(2):148-54. PubMed ID: 19232532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy.
    Schek RM; Hollister SJ; Krebsbach PH
    Mol Ther; 2004 Jan; 9(1):130-8. PubMed ID: 14741786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sponge-mediated lentivirus delivery to acute and chronic spinal cord injuries.
    Thomas AM; Palma JL; Shea LD
    J Control Release; 2015 Apr; 204():1-10. PubMed ID: 25724274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano polydopamine crosslinked thiol-functionalized hyaluronic acid hydrogel for angiogenic drug delivery.
    Yegappan R; Selvaprithiviraj V; Mohandas A; Jayakumar R
    Colloids Surf B Biointerfaces; 2019 May; 177():41-49. PubMed ID: 30711759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized viral vector delivery to enhance in situ regenerative gene therapy.
    Hu WW; Wang Z; Hollister SJ; Krebsbach PH
    Gene Ther; 2007 Jun; 14(11):891-901. PubMed ID: 17344901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylserine immobilization of lentivirus for localized gene transfer.
    Shin S; Tuinstra HM; Salvay DM; Shea LD
    Biomaterials; 2010 May; 31(15):4353-9. PubMed ID: 20206382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating polymer chemistry to enhance non-viral gene delivery inside hydrogels with tunable matrix stiffness.
    Keeney M; Onyiah S; Zhang Z; Tong X; Han LH; Yang F
    Biomaterials; 2013 Dec; 34(37):9657-65. PubMed ID: 24011715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.